- New Compound May Protect Against Liver Cancer, February 15, 2006 News Release - Natio
- Anti-cancer drug side effect cause found - Science
- Possible Therapeutic Peptide for Hepatocellular Carcionoma
- Study shows liver an excellent target for cancer gene therapy using viral vectors
- Mailman School of Public Health researchers report blood DNA can be early predictor o
- Correlating Gene Expression with CT Scan imaging
- Nexavar significantly extends overall survival by 44 percent in liver cancer patients
- Ablation procedure proves safe, effective and fast
- Antibody retards growth and induces death in liver cancer cells
- Targeting nerve growth factor may cure liver cancer
- Tiny radioactive spheres effectively treat cancer that has spread to the liver
- Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at
- Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
- High-energy ultrasound sharpens view of liver tumors
- Moffitt seeking participants for advanced liver cancer study
- Proteomic profiling shown more accurate than traditional biomarkers in identifying li
- MIT: Why men are more prone to liver cancer
- Discovery of good -- and bad -- liver stem cells raises possibility of new treatment
- Combined stenting and photodynamic therapy improves survival in late stage liver canc
- Penn researchers find targeted therapy combination overcomes treatment resistance in
- Coffee consumption may curb liver cancer risk
- Liver Transplant Recipients with Hepatitis B May Need Lifelong Antiviral Treatment
- Scientists identify specific markers that trigger aggressiveness of liver cancer
- Can Biopsies of Liver Metastases Improve Treatment Choice?
- Nexavar shown significant extended survival for patients with advanced liver cancer
- Liver Cancer Risk May Be Reduced By Vitamin E
- Surgery May Be Best for Early Liver Cancer
- Novel Agent Shows Promise in Advanced Liver Cancer
- New ablation technique holds promise for liver cancer patients